These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19106153)

  • 1. Are drug-eluting stents safe in the long term?
    Généreux P; Mehran R
    CMAJ; 2009 Jan; 180(2):154-5. PubMed ID: 19106153
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term outcomes of patients receiving drug-eluting stents.
    Philpott AC; Southern DA; Clement FM; Galbraith PD; Traboulsi M; Knudtson ML; Ghali WA;
    CMAJ; 2009 Jan; 180(2):167-74. PubMed ID: 19095719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of drug-eluting stents.
    Windecker S; Jüni P
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
    Chhatriwalla AK; Bhatt DL
    Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stents: effective and safe for every patient and every lesion?
    Zeymer U; Zahn R
    Eur Heart J; 2007 Nov; 28(21):2559-60. PubMed ID: 17938127
    [No Abstract]   [Full Text] [Related]  

  • 7. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely.
    Colombo A; Gerber RT
    Circ Cardiovasc Interv; 2008 Dec; 1(3):226-32. PubMed ID: 20031682
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-eluting stent thrombosis.
    Steinberg DH; Satler LF
    Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of drug eluting stents: current concerns and controversies.
    Raja SG; Berg GA
    Curr Drug Saf; 2007 Sep; 2(3):212-9. PubMed ID: 18690970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving management of patients treated by drug-eluting stent: prevention of late events.
    Niccoli G; Sgueglia GA; Montone RA; Roberto M; Banning AP; Crea F
    Cardiovasc Revasc Med; 2014 Mar; 15(2):100-8. PubMed ID: 24603193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 13. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract]   [Full Text] [Related]  

  • 14. Live by the sword, die by the sword.
    Moreno R; Macaya C
    South Med J; 2008 Feb; 101(2):123-4. PubMed ID: 18364608
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpreting the music of drug-eluting stents: halcyon song or albatross dirge?
    Mark DB
    J Am Coll Cardiol; 2008 May; 51(19):1854-6. PubMed ID: 18466799
    [No Abstract]   [Full Text] [Related]  

  • 16. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.
    Torrado J; Buckley L; Durán A; Trujillo P; Toldo S; Valle Raleigh J; Abbate A; Biondi-Zoccai G; Guzmán LA
    J Am Coll Cardiol; 2018 Apr; 71(15):1676-1695. PubMed ID: 29650125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable coating for drug-eluting stents--more than a facelift?
    Niemelä KO
    Eur Heart J; 2008 Aug; 29(16):1930-1. PubMed ID: 18586664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug-eluting stents--for all, for some or for none?--Editorial].
    Kocka V; Widimský P
    Vnitr Lek; 2007 Oct; 53(10):1033-4. PubMed ID: 18072425
    [No Abstract]   [Full Text] [Related]  

  • 19. Is implantation of drug-eluting stents a Faustian choice?
    Brener SJ
    J Invasive Cardiol; 2010 Oct; 22(10):465-6. PubMed ID: 20944184
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
    Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
    J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.